MBBS, MD, Facharzt (Ped), Facharzt (Ped Hema/Onco), MBA (RCSI)
Senior consultant pediatric oncologist specializing in childhood cancer and blood disorders
Experience
—
Languages
Arabic, English
Location
Dubai Healthcare City, Dubai
Sees
children
Dr Abdulrahman Al Jassmi is a senior consultant pediatric oncologist with over 25 years of experience treating children with cancer and blood diseases. He completed his pediatric residency at the University of Bonn in Germany in 1995, followed by specialized training in pediatric hematology and oncology at Sankt Augustin Children University Hospital, Germany, which he finished in 1998. He also holds an MBA in Healthcare Management from the Royal College of Surgeons in Ireland (2015). Dr Al Jassmi has led the pediatric hematology and oncology department at Dubai Hospital since 2004 and is widely published in peer-reviewed journals on his research.
His clinical expertise spans childhood cancers, benign and malignant blood disorders, and post-bone marrow transplant care. He has served as a mentor to numerous pediatric medical students, residents, and fellows and has been instrumental in advancing pediatric oncology in the region through his participation in European cancer treatment protocols and his involvement with leading international cancer research organizations.
Dr Al Jassmi holds significant leadership roles across regional and international bodies, including membership of the Cancer Advisory Board of the UAE Ministry of Health, the International Network for Cancer Treatment and Research (INCTR), the Middle East Childhood Cancer Alliance (MECCA), and the Arab Gulf Federation of Cancer Control. He previously served as Chief Executive Officer of Dubai Hospital until 2018. He is an excellent choice for families seeking expert pediatric cancer care and hematology treatment with a deeply experienced clinician who combines clinical excellence with a strong commitment to training the next generation of specialists.
Special interests: pediatric cancer treatment protocols, blood diseases in children, mentoring pediatric oncology fellows and residents, cancer research and clinical trials.
Extracted from the doctor's hospital profile — patient-friendly terms
MBBS
unknown
MD
unknown
Residency in Pediatrics
University of Bonn, Germany · 1995
Residency in Pediatric Hematology/Oncology
Sankt Augustin Children University Hospital, Germany · 1998
MBA in Healthcare Management
Royal College of Surgeons in Ireland, Ireland · 2015
Senior Consultant and Head of Pediatric Hematology/Oncology
Dubai Hospital, United Arab Emirates · 2004–present
Consultant Pediatrician, Hematologist & Oncologist
Mediclinic City Hospital, United Arab Emirates
Chief Executive Officer
Dubai Hospital, United Arab Emirates · until 2018
Resident in Pediatric Hematology/Oncology
Sankt Augustin Children University Hospital, Germany · 1995–1998
Resident in Pediatrics
University of Bonn, Germany · until 1995
Consultations are available in Arabic, English.
Mediclinic — Mediclinic City Hospital Consultant Paediatrician Haemotologist & Oncologist In department Paediatric Oncology/Haematology Mediclinic City Hospital Comprehensive Cancer Centre Consultant Paediatrician Haemotologist & Oncologist In department Paediatric Oncology/Haematology, Dubai Healthcare City, Dubai.
Yes — this doctor sees children.
Commonly treated: Benign Blood Disorders, Blood Cell Abnormalities, Bone Tumors, Brain Tumors, Childhood Cancer, Leukemia, Lymphoma.
Profile compiled from Mediclinic's public website (see original profile via the booking link). Data is informational, not medical advice.
Mediclinic City Hospital
Bldg 37 - 26th St - Umm Hurair 2 - Dubai Healthcare City - Dubai
+971 800 1999Mediclinic City Hospital: 3.8★ · 2,416 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Abdulrahman Al Jassmi (ID*)? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.